Industry: Chemical & Material
Published Date: 2024-02-14
Pages: 98 Pages
Report ld: 2501713
Request Sample
Customized Report
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
The global Semi-Solid Dose market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Semi-Solid Dose is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Semi-Solid Dose is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Semi-Solid Dose include Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Nestle SA, Novartis AG and GlaxoSmithKline plc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Semi-Solid Dose, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Semi-Solid Dose.
MARKET SEGMENTATION
REPORT SCOPE
The Semi-Solid Dose market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Semi-Solid Dose market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Semi-Solid Dose manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Semi-Solid Dose manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Semi-Solid Dose by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Semi-Solid Dose in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Semi-Solid Dose Market Overview
1.1 Product Definition
1.2 Semi-Solid Dose Segment by Type
1.2.1 Global Semi-Solid Dose Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Ointments
1.2.3 Pastes
1.2.4 Gels
1.3 Semi-Solid Dose Segment by Application
1.3.1 Global Semi-Solid Dose Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Skin
1.3.3 Nasal Cavity
1.3.4 Vaginal Cavity
1.3.5 Rectal Cavity
1.3.6 Others
1.4 Global Market Growth Prospects
1.4.1 Global Semi-Solid Dose Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Semi-Solid Dose Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Semi-Solid Dose Production Estimates and Forecasts (2019-2030)
1.4.4 Global Semi-Solid Dose Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Semi-Solid Dose Production Market Share by Manufacturers (2019-2024)
2.2 Global Semi-Solid Dose Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Semi-Solid Dose, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Semi-Solid Dose Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Semi-Solid Dose Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Semi-Solid Dose, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Semi-Solid Dose, Product Offered and Application
2.8 Global Key Manufacturers of Semi-Solid Dose, Date of Enter into This Industry
2.9 Semi-Solid Dose Market Competitive Situation and Trends
2.9.1 Semi-Solid Dose Market Concentration Rate
2.9.2 Global 5 and 10 Largest Semi-Solid Dose Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Semi-Solid Dose Production by Region
3.1 Global Semi-Solid Dose Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Semi-Solid Dose Production Value by Region (2019-2030)
3.2.1 Global Semi-Solid Dose Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Semi-Solid Dose by Region (2025-2030)
3.3 Global Semi-Solid Dose Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Semi-Solid Dose Production by Region (2019-2030)
3.4.1 Global Semi-Solid Dose Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Semi-Solid Dose by Region (2025-2030)
3.5 Global Semi-Solid Dose Market Price Analysis by Region (2019-2024)
3.6 Global Semi-Solid Dose Production and Value, Year-over-Year Growth
3.6.1 North America Semi-Solid Dose Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Semi-Solid Dose Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Semi-Solid Dose Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Semi-Solid Dose Production Value Estimates and Forecasts (2019-2030)
4 Semi-Solid Dose Consumption by Region
4.1 Global Semi-Solid Dose Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Semi-Solid Dose Consumption by Region (2019-2030)
4.2.1 Global Semi-Solid Dose Consumption by Region (2019-2024)
4.2.2 Global Semi-Solid Dose Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Semi-Solid Dose Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Semi-Solid Dose Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Semi-Solid Dose Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Semi-Solid Dose Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Semi-Solid Dose Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Semi-Solid Dose Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Semi-Solid Dose Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Semi-Solid Dose Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Semi-Solid Dose Production by Type (2019-2030)
5.1.1 Global Semi-Solid Dose Production by Type (2019-2024)
5.1.2 Global Semi-Solid Dose Production by Type (2025-2030)
5.1.3 Global Semi-Solid Dose Production Market Share by Type (2019-2030)
5.2 Global Semi-Solid Dose Production Value by Type (2019-2030)
5.2.1 Global Semi-Solid Dose Production Value by Type (2019-2024)
5.2.2 Global Semi-Solid Dose Production Value by Type (2025-2030)
5.2.3 Global Semi-Solid Dose Production Value Market Share by Type (2019-2030)
5.3 Global Semi-Solid Dose Price by Type (2019-2030)
6 Segment by Application
6.1 Global Semi-Solid Dose Production by Application (2019-2030)
6.1.1 Global Semi-Solid Dose Production by Application (2019-2024)
6.1.2 Global Semi-Solid Dose Production by Application (2025-2030)
6.1.3 Global Semi-Solid Dose Production Market Share by Application (2019-2030)
6.2 Global Semi-Solid Dose Production Value by Application (2019-2030)
6.2.1 Global Semi-Solid Dose Production Value by Application (2019-2024)
6.2.2 Global Semi-Solid Dose Production Value by Application (2025-2030)
6.2.3 Global Semi-Solid Dose Production Value Market Share by Application (2019-2030)
6.3 Global Semi-Solid Dose Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Semi-Solid Dose Corporation Information
7.1.2 Johnson & Johnson Semi-Solid Dose Product Portfolio
7.1.3 Johnson & Johnson Semi-Solid Dose Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Johnson & Johnson Main Business and Markets Served
7.1.5 Johnson & Johnson Recent Developments/Updates
7.2 Merck & Co
7.2.1 Merck & Co Semi-Solid Dose Corporation Information
7.2.2 Merck & Co Semi-Solid Dose Product Portfolio
7.2.3 Merck & Co Semi-Solid Dose Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Merck & Co Main Business and Markets Served
7.2.5 Merck & Co Recent Developments/Updates
7.3 Bayer AG
7.3.1 Bayer AG Semi-Solid Dose Corporation Information
7.3.2 Bayer AG Semi-Solid Dose Product Portfolio
7.3.3 Bayer AG Semi-Solid Dose Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Bayer AG Main Business and Markets Served
7.3.5 Bayer AG Recent Developments/Updates
7.4 Hisamitsu Pharmaceutical
7.4.1 Hisamitsu Pharmaceutical Semi-Solid Dose Corporation Information
7.4.2 Hisamitsu Pharmaceutical Semi-Solid Dose Product Portfolio
7.4.3 Hisamitsu Pharmaceutical Semi-Solid Dose Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Hisamitsu Pharmaceutical Main Business and Markets Served
7.4.5 Hisamitsu Pharmaceutical Recent Developments/Updates
7.5 Glenmark Pharmaceuticals
7.5.1 Glenmark Pharmaceuticals Semi-Solid Dose Corporation Information
7.5.2 Glenmark Pharmaceuticals Semi-Solid Dose Product Portfolio
7.5.3 Glenmark Pharmaceuticals Semi-Solid Dose Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Glenmark Pharmaceuticals Main Business and Markets Served
7.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.6 Cipla Ltd
7.6.1 Cipla Ltd Semi-Solid Dose Corporation Information
7.6.2 Cipla Ltd Semi-Solid Dose Product Portfolio
7.6.3 Cipla Ltd Semi-Solid Dose Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Cipla Ltd Main Business and Markets Served
7.6.5 Cipla Ltd Recent Developments/Updates
7.7 Nestle SA
7.7.1 Nestle SA Semi-Solid Dose Corporation Information
7.7.2 Nestle SA Semi-Solid Dose Product Portfolio
7.7.3 Nestle SA Semi-Solid Dose Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Nestle SA Main Business and Markets Served
7.7.5 Nestle SA Recent Developments/Updates
7.8 Novartis AG
7.8.1 Novartis AG Semi-Solid Dose Corporation Information
7.8.2 Novartis AG Semi-Solid Dose Product Portfolio
7.8.3 Novartis AG Semi-Solid Dose Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Novartis AG Main Business and Markets Served
7.7.5 Novartis AG Recent Developments/Updates
7.9 GlaxoSmithKline plc
7.9.1 GlaxoSmithKline plc Semi-Solid Dose Corporation Information
7.9.2 GlaxoSmithKline plc Semi-Solid Dose Product Portfolio
7.9.3 GlaxoSmithKline plc Semi-Solid Dose Production, Value, Price and Gross Margin (2019-2024)
7.9.4 GlaxoSmithKline plc Main Business and Markets Served
7.9.5 GlaxoSmithKline plc Recent Developments/Updates
7.10 Bausch Health Companies
7.10.1 Bausch Health Companies Semi-Solid Dose Corporation Information
7.10.2 Bausch Health Companies Semi-Solid Dose Product Portfolio
7.10.3 Bausch Health Companies Semi-Solid Dose Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Bausch Health Companies Main Business and Markets Served
7.10.5 Bausch Health Companies Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Semi-Solid Dose Industry Chain Analysis
8.2 Semi-Solid Dose Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Semi-Solid Dose Production Mode & Process
8.4 Semi-Solid Dose Sales and Marketing
8.4.1 Semi-Solid Dose Sales Channels
8.4.2 Semi-Solid Dose Distributors
8.5 Semi-Solid Dose Customers
9 Semi-Solid Dose Market Dynamics
9.1 Semi-Solid Dose Industry Trends
9.2 Semi-Solid Dose Market Drivers
9.3 Semi-Solid Dose Market Challenges
9.4 Semi-Solid Dose Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-01
Pages: 105
USD 3950.00
(Single User License)
The global Semi-Solid Dose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-01
Pages: 130
USD 2900.00
(Single User License)
The global Semi-Solid Dose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 142
USD 4900.00
(Single User License)
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 99
USD 3950.00
(Single User License)
The global Semi-Solid Dose market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 76
USD 4250.00
(Single User License)
The global market for Semi-Solid Dose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-14
Pages: 94
USD 2900.00
(Single User License)
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published Date: 2024-01-04
Pages: 130
USD 3950.00
(Single User License)
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-01
Pages: 105
The global Semi-Solid Dose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-01
Pages: 130
The global Semi-Solid Dose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 142
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 99
The global Semi-Solid Dose market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 76
The global market for Semi-Solid Dose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-14
Pages: 94
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published: 2024-04-10
Pages: 112
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published: 2024-01-04
Pages: 130
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now